Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05654532 |
| Title | Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Accutar Biotechnology Inc |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Site 08 | Denver | Colorado | 80218 | United States | Details | |
| Site 07 | Orlando | Florida | 32746 | United States | Details | |
| Site 02 | Sarasota | Florida | 34232 | United States | Details | |
| Site 06 | Rockville | Maryland | 21044 | United States | Details | |
| Site 01 | Nashville | Tennessee | 37203 | United States | Details | |
| Site 03 | Houston | Texas | 77030 | United States | Details | |
| Site 09 | San Antonio | Texas | 78240 | United States | Details | |
| Site 05 | Norfolk | Virginia | 23502 | United States | Details | |
| Site 04 | Vancouver | Washington | 98684 | United States | Details |